PPARA and hepatocellular carcinoma: Treatment with GW6471 significantly reversed the Linc01056 knockdown-induced increase in the OCR in sorafenib-treated HCC cells, while the increase of ECAR upon PPARα inhibition was subtle (Fig. 5f and g).